INS and cancer: Eighteen signalling pathways were enriched with the criteria of 2 fold changes and p<0.05 (Table 3), which include the Insulin, Tyrosine metabolism, cell cycle, gap junction, calcium, energy metabolism, p53, cardio function associated signalling pathways and some cancer signalling pathways.